VENUSREM — Venus Remedies Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹4.99bn
- IN₹4.53bn
- IN₹6.01bn
- 92
- 60
- 78
- 93
Annual cashflow statement for Venus Remedies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2020 March 31st | C2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 7.77 | 251 | 364 | 379 | 446 |
| Depreciation | |||||
| Non-Cash Items | 240 | 108 | -63.1 | -89.7 | -62.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 208 | 607 | -226 | -246 | -276 |
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 776 | 1,318 | 410 | 366 | 373 |
| Capital Expenditures | -77.8 | -77.3 | -137 | -78.2 | -135 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 30.3 | 642 | -29.2 | -430 | 63.1 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -47.5 | 565 | -166 | -508 | -72.1 |
| Financing Cash Flow Items | -121 | -70.2 | -4.62 | -1.18 | -0.9 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -730 | -1,622 | -94.8 | -5.67 | -10.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.907 | 269 | 144 | -220 | 277 |